Filing Details

Accession Number:
0001209191-12-009594
Form Type:
5
Zero Holdings:
No
Publication Time:
2012-02-13 17:37:16
Reporting Period:
2011-12-31
Filing Date:
2012-02-13
Accepted Time:
2012-02-13 17:37:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1347178 Vanda Pharmaceuticals Inc. VNDA Pharmaceutical Preparations (2834) 030491827
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1454240 Joseph John Feeney 9605 Medical Center Drive
Suite 300
Rockville MD 20850
Svp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-18 7,500 $0.00 7,500 No 5 M Direct
Common Stock Disposition 2011-02-18 2,985 $7.25 4,515 No 5 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 M Direct
No 5 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2011-02-18 7,500 $0.00 7,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,500 No 5 M Direct
Footnotes
  1. Each Restricted Stock Unit represents a contingent right to receive a share of the Issuer's common stock.
  2. The Restricted Stock Units vest in four equal annual installments beginning January 1, 2011. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
  3. N/A